Soluble complement receptor type 1 (sCR1) in chronic liver diseases: Serum levels at different stages of liver diseases

Clinical and Experimental Immunology

Volumn 114, Issue 1, 1998, Pages 102-105

  Di Bona, D ^a   Montalto, G ^b   Clemenza, L ^a   Bascone, F ^b   Accardo, P ^a   Bellavia, D ^a   Craxi A ^c   Brai, M ^a,d  

^a Istituto di Patologia Generale   (Italy)

^b Istituto di Medicina Interna I   (Italy)

^c UNIVERSITY OF PALERMO   (Italy)

^d Istituto di Patologia Generale   (Italy)

Author keywords

Child Pugh; Hepatocellular carcinoma; Liver disease; Soluble CR1

Indexed keywords

COMPLEMENT RECEPTOR;

ARTICLE; BLOOD LEVEL; CHRONIC LIVER DISEASE; DISEASE SEVERITY; HUMAN; LIVER CANCER; LIVER CIRRHOSIS; LIVER FUNCTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER DISEASES; RECEPTORS, COMPLEMENT;

EID: 0031708725     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00707.x     Document Type: Article

References (22)

1. Fearon DT. Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leucocyte, B lymphocyte, and monocyte. J Exp Med 1980; 152:20-30.
2. Pascual M, Steiger G, Sadallah S, Paccaud JP, Carpentier JL, Jamer RJ, Schifferli JA. Identification of membrane-bound CR1 (CD35) in human urine: evidence for its release by glomerular podocytes. J Exp Med 1994; 179:889-99.
3. Herbert LA, Cosio FG, Birmingham DJ, Mahan JD. Biological significance of the erythrocyte complement receptor: a primate perquisite. J Lab Clin Med 1991; 118:301-8.
4. Herbert LA. The clearance of immune complexes from the circulation of man and other primates. Am J Kidney Dis 1991; 3:352-61.
5. Medof ME, Iida K, Mold C, Nussenzweig V. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes. J Exp Med 1982; 156:1739-54.
6. Hourcade D, Holers VM, Atkinson JP. The regulators of complement activation (RCA) gene cluster. Adv Immunol 1989; 45:381-415.
7. Weisman HF, Barlow T, Leppo MK et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990; 249:146-51.
8. 2 chimeric complement inhibitor. J Exp Med 1991; 174:1451-60.
9. Yoon SH, Fearon DT. Characterization of a soluble form of C3b/C4b receptor (CR1) in human plasma. J Immunol 1985; 134:3332-7.
10. Danielsson C, Pascual M, French L, Steiger G, Schifferli JA. Soluble complement receptor type 1 (CD35) is released from leucocytes by surface cleavage. Eur J Immunol 1994; 24:2725-31.
11. Pascual M, Duchosal MA, Steiger G, Giostra E, Pechere A, Paccaud JP, Danielsson C, Schifferli JA. Circulating soluble CR1 (CD35). J Immunol 1993; 151:1702-11.
12. Albers I, Hartman H, Bircher J, Creutzfeldt W. Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol 1989; 24:269-76.
13. Edberg JC, Kimberly RP, Taylor RP. Functional characterization of non-human primate erythrocyte immune adherence receptors: implications for the uptake of immune complexes by the cells of the mononuclear phagocytic system. Eur J Immunol 1992; 22:1333-9.
14. Quadri RA, Schifferli JA. Over-estimation of the number of complement receptor type 1 (CR1) on erythrocytes. Scand J Immunol 1992; 36:125-30.
15. Madi N, Paccaud JP, Steiger G, Schifferli JA. Immune complex binding efficiency of erythrocyte complement receptor 1. Clin Exp Immunol 1991; 84:9-15.
16. Sadallah S, Giostra E, Mentha G, Schifferli JA. Increased levels of soluble complement receptor 1 in serum of patients with liver diseases. Hepatology 1996; 24:118-22.
17. Deviere J, Content C, Denys C, Vandenbussche P, Schandene L, Wybran J, Dupont E. High interleukin-6 levels and increased production by leucocytes in alcoholic liver cirrhosis. Correlation with IgA serum levels and lymphokine production. Clin Exp Immunol 1989; 77:221-5.
18. Rosenbloom AJ, Pinsky MR, Bryant JL, Shin A, Tran T, Whiteside T. Leucocyte activation in the peripheral blood of patients with cirrhosis of the liver and SIRS. JAMA 1995; 247:58-65.
19. Byl B, Roucloux I, Crusiaux A, Dupont E, Deviere J. Tumor necrosis factor alpha and interleukin-6 plasma levels in infected cirrhotic patients. Gastroenterology 1993; 104:1492-7.
20. Kuo CH, Changchien CS, Yang CY, Sheen IS, Liaw YF. Bacteremia in patients with cirrhosis of the liver. Liver 1991; 11:334-9.
21. Hinglais N, Kazatchkine MD, Mandet C, Appay MD, Bariety J. Human liver Kupffer cells express CR1, CR2 and CR4 complement receptor antigens. Lab Invest 1989; 61:509-14.
22. Kanto T, Hayashi N, Takehara T et al. Low expression of erythrocyte complement receptor type 1 in chronic hepatitis C patients. J Med Virol 1996; 50:126-34.